Abstract
Background: While recent pieces of evidence suggest that discontinuation of levothyroxine replacement therapy (LRT) earlier than the current guidelines of 3 years is possible, the optimal duration of LRT for delayed hyperthyrotropinemia in extremely low birth weight infants (ELBWIs) remains unknown. Objective: This study aimed to investigate the feasibility of early discontinuation of LRT for delayed hyperthyrotropinemia in ELBWIs. Methods: The medical records of 92 ELBWIs who had shown delayed hyperthyrotropinemia, defined as a delayed rise in thyroid-stimulating hormone (TSH) levels to >20 µIU/mL after initial normal TSH level, were retrospectively reviewed to determine whether the duration of LRT affects the short-term outcomes at discharge from neonatal intensive care unit (NICU) and the long-term outcomes at the corrected age (CA) of 2 years. The infants were grouped into: no LRT required group (n = 21), short-term LRT given until the time of NICU discharge – 90 ± 64 (13–211) days group (n = 36), and long-term LRT given – 749 ± 333 (339–1,967) days group (n = 35). Results: While mortality in the no LRT required group was significantly higher than that in the long-term LRT group, no significant differences were observed in short-term outcomes at discharge from NICU and long-term growth and neurodevelopmental outcomes at CA of 2 years between the short- and long-term LRT groups. Conclusions: Termination of LRT at around the time of discharge from NICU in well, clinically stable ELBWIs who have delayed hyperthyrotropinemia appears to be safe and feasible and avoids the risk of overtreatment.
References
1.
Léger
J
, Olivieri
A
, Donaldson
M
, Torresani
T
, Krude
H
, Van Vliet
G
, . European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism
. Horm Res Paediatr
. 2014
;81
(2
):80
–103
.2.
Lim
G
, Lee
YK
, Han
HS
. Early discontinuation of thyroxine therapy is possible in most very low-birthweight infants with hypothyroidism detected by screening
. Acta Paediatr
. 2014
;103
(3
):e123
–e129
.3.
Yoon
SA
, Chang
YS
, Ahn
SY
, In Sung
S
, Park
WS
. Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants
. BMC Pediatr
. 2019
;19
(1
):347
–9
.4.
Woo
HC
, Lizarda
A
, Tucker
R
, Mitchell
ML
, Vohr
B
, Oh
W
, . Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes
. J Pediatr
. 2011
;158
(4
):538
–42
.5.
Caiulo
S
, Corbetta
C
, Di Frenna
M
, Medda
E
, De Angelis
S
, Rotondi
D
, . Newborn screening for congenital hypothyroidism: the benefit of using differential TSH cutoffs in a 2-screen program
. J Clin Endocrinol Metab
. 2020
;106
(1
):e338
–e349
.6.
Van Vliet
G
, Diaz Escagedo
P
. Redefining congenital hypothyroidism
. J Clin Endocrinol Metab
. 2021
;106
(3
):e1463
–e1465
.7.
Klein
R
. Effects of neonatal screening for hypothyroidism-prevention of mental-retardation by treatment before clinical manifestations
. Lancet
. 1981
;2
(8255
):1095
–8
.8.
Hyman
SJ
, Greig
F
, Holzman
I
, Patel
A
, Wallach
E
, Rapaport
R
. Late rise of thyroid stimulating hormone in ill newborns
. J Pediatr Endocrinol Metab
. 2007
;20
(4
):501
–10
.9.
Collaborative
NECH
. Elementary school performance of children with congenital hypothyroidism
. J Pediatr
. 1990
;116
(1
):27
–32
.10.
Patel
J
, Landers
K
, Li
H
, Mortimer
RH
, Richard
K
. Thyroid hormones and fetal neurological development
. J Endocrinol
. 2011
;209
(1
):1
–8
.11.
American Academy of Pediatrics
, Rose
SR
, Section on Endocrinology and Committee on Genetics
, American Thyroid Association
, Brown
RS
, Public Health Committee
, . Update of newborn screening and therapy for congenital hypothyroidism
. Pediatrics
. 2006
;117
(6
):2290
–303
.12.
Jung
JM
, Jin
HY
, Chung
ML
. Feasibility of an early discontinuation of thyroid hormone treatment in very-low-birth-weight infants at risk for transient or permanent congenital hypothyroidism
. Horm Res Paediatr
. 2016
;85
(2
):131
–9
.13.
Kemper
AR
, Grosse
SD
, Baker
M
, Pollock
AJ
, Hinton
CF
, Shapira
SK
. Treatment discontinuation within 3 years of levothyroxine initiation among children diagnosed with congenital hypothyroidism
. J Pediatr
. 2020
;223
:136
–40
.14.
Mitchell
ML
, Hsu
HW
, Sahai
I
, Massachusetts Pediatric Endocrine Work Group
. The increased incidence of congenital hypothyroidism: fact or fancy
. Clin Endocrinol
. 2011
;75
(6
):806
–10
.15.
Iijima
S
. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat
. J Matern Fetal Neonatal Med
. 2019
;32
(15
):2591
–7
.16.
Jobe
AH
, Bancalari
E
. Bronchopulmonary dysplasia
. Am J Respir Crit Care Med
. 2001
;163
(7
):1723
–9
.17.
Papile
LA
, Burstein
J
, Burstein
R
, Koffler
H
. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm
. J Pediatr
. 1978
;92
(4
):529
–34
.18.
Bell
MJ
, Ternberg
JL
, Feigin
RD
, Keating
JP
, Marshall
R
, Barton
L
, . Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging
. Ann Surg
. 1978
;187
(1
):1
–7
.19.
Moon
JS
, Lee
SY
, Nam
CM
, Choi
J-M
, Choe
B-K
, Seo
J-W
, . 2007 Korean National Growth Charts: review of developmental process and an outlook
. Clin Exp Pediatr
. 2008
;51
(1
):1
–25
.20.
Palisano
R
, Rosenbaum
P
, Walter
S
, Russell
D
, Wood
E
, Galuppi
B
. Development and reliability of a system to classify gross motor function in children with cerebral palsy
. Dev Med Child Neurol
. 1997
;39
(4
):214
–23
.21.
Watkins
PL
, Dagle
JM
, Bell
EF
, Colaizy
TT
. Outcomes at 18 to 22 months of corrected age for infants born at 22 to 25 weeks of gestation in a center practicing active management
. J Pediatr
. 2020
;217
:52
–8.e1
.22.
Kaplowitz
PB
. Neonatal thyroid disease. Current advances in neonatal care, an issue of pediatric clinics of North America
. 2019
. Vol. 66
; p. 343
–52
.23.
Yoon
SA
, Chang
YS
, Ahn
SY
, Sung
SI
, Park
WS
. Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants
. Sci Rep
. 2019
;9
(1
):9628
–7
.24.
Vigone
MC
, Caiulo
S
, Di Frenna
M
, Ghirardello
S
, Corbetta
C
, Mosca
F
, . Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism
. J Pediatr
. 2014
;164
(6
):1296
–302
.25.
Léger
J
, Olivieri
A
, Donaldson
M
, Torresani
T
, Krude
H
, van Vliet
G
, . European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism
. J Clin Endocrinol Metab
. 2014
;99
(2
):363
–84
.© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.
